INVESTOR AB
13F Reported Value
ⓘ$14.4B
Holdings
7
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
INVESTOR AB disclosed 7 positions worth $14.4B in its Form 13F-HR for Q2 2026, led by $AZN (ASTRAZENECA PLC) at 67.9% of the equity portfolio, followed by $NDAQ and $MDWD. During the quarter the fund opened 1 new position and exited 4 — including a new stake in $MU and a full exit from $COHR. The portfolio is most concentrated in Healthcare (68.0% of disclosed assets). All figures are sourced directly from INVESTOR AB’s Form 13F-HR filing with the SEC under CIK 889232.
AI Fund Analysis
StableSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- —
Quality
$9.8B51,587,810 sh - 76.7#80
Quality
$4.6B58,439,208 sh - —
Quality
$12.8M872,093 sh - —
Quality
$1.1M75,000 sh - 86.2
Quality
$542.5K470 sh - 65.8
Quality
$478.4K11,300 sh - 58.2
Quality
$211.7K3,700 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| — | $9.8B | 51,587,810 | |
| 76.7#80 | $4.6B | 58,439,208 | |
| — | $12.8M | 872,093 | |
| — | $1.1M | 75,000 | |
| 86.2 | $542.5K | 470 | |
| 65.8 | $478.4K | 11,300 | |
| 58.2 | $211.7K | 3,700 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of INVESTOR AB's 7 positions.
Showing top 7 of 7 holdings.
Sector Allocation
Healthcare
$9.8B
Financials
$4.6B
Technology
$1.6M
Communication Services
$478,442
Full Holdings — INVESTOR AB (Q2 2026)
All 7 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | ASTRAZENECA PLC | $9.8B | 67.9% | +0% | — | |
| 2 | NASDAQ, INC. | $4.6B | 32.0% | +0% | 76.7 | |
| 3 | MediWound Ltd. | $12.8M | 0.1% | +0% | — | |
| 4 | Cellebrite DI Ltd. | $1.1M | 0.0% | +36% | — | |
| 5 | MICRON TECHNOLOGY INC | $542,516 | 0.0% | NEW | 86.2 | |
| 6 | VERIZON COMMUNICATIONS INC | $478,442 | 0.0% | +0% | 65.8 | |
| 7 | BIOMARIN PHARMACEUTICAL INC | $211,714 | 0.0% | +0% | 58.2 |
New Positions (1)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for INVESTOR AB including:
Track INVESTOR AB's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for INVESTOR AB and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: INVESTOR AB
13F Pro is an AI hedge fund tracker and stock research platform. For INVESTOR AB (SEC CIK: 889232), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in INVESTOR AB's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.